Skip to main content
Home >> Labelling News >> Falsified Medicines Directive (FMD) Safety Features

Falsified Medicines Directive (FMD) Safety Features

"The Falsified Medicines Directive (FMD) will be rolled out in Europe from February 2019 to address the threat of fake medicines and will impact the entire supply chain..."

Under the Falsified Medicines Directive (FMD) Delegated Regulation (EU2016/161), all new packs of prescription medicines put on the market from 9th February 2019 will have two safety features:

  1. A unique identifier or 'UI' (a 2D data matrix code and human readable information) which will be placed on medical products that can be scanned at fixed points along the supply chain

  2. Tamper evident features (anti-tampering device or 'ATD') on the pack.

Weyfringe can help you to fulfil this requirement with our range of Easylabel software, thermal barcode label printers and 2D barcode verifiers.

 

Click here for more information

If you would like to arrange a FREE no obligation demonstration please follow the link below or call 01642 490121

Arrange a demonstration